Clinical Trials Logo

Filter by:
NCT ID: NCT02938364 Recruiting - Gagging Clinical Trials

Ear Plugs Versus Acupressure for Management of Severe Gag Reflex

Start date: October 25, 2016
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of two proposed non-invasive techniques: the ear plug technique and acupressure on the P6 point in reducing gag reflex during impression making and to assess patient's experience in terms of comfort and satisfaction.

NCT ID: NCT02936830 Completed - Clinical trials for Dentin Hypersensitivity

Effectiveness of Nanohydroxyapetite Paste on Reducing Dentin Hypersensitivity

Start date: October 2016
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the efficacy of dentine hypersensitivity reduction using in office paste formula containing nanoHydroxyapatite with the commercially available fluoride (duraphat) and a placebo in treating hypersensitivity in a single visit.

NCT ID: NCT02935088 Completed - Clinical trials for Coronary Artery Disease

PRESSUREwire Study

Start date: October 12, 2016
Phase:
Study type: Observational

The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.

NCT ID: NCT02928406 Completed - Clinical trials for Urinary Tract Cancer

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

Start date: November 30, 2016
Phase: Phase 3
Study type: Interventional

This Phase IIIb, multicenter study will assess the safety of atezolizumab as second- to fourth-line treatment for participants with locally advanced or metastatic urothelial or non-urothelial cancer of the urinary tract in addition to evaluate the efficacy of atezolizumab and potential tumor biomarkers associated with atezolizumab.

NCT ID: NCT02925208 Completed - Clinical trials for Undergoing Cochlear Implant Surgery

Radiological Classification of the Facial Nerve

Start date: January 2010
Phase: N/A
Study type: Observational

Cortical mastoidectomy and posterior tympanotomy is a classic approach for cochlear implant. Intimate knowledge of the relevant surgical anatomy of the temporal bone and facial recess is important to safely perform the posterior tympanotomy. Anatomical variation of facial nerve such as lateral or anterior position of vertical segment of facial nerve, will render this approach challenging. In this research, investigators proposed a Radiological Classification system of the position of vertical segment of facial nerve in relation to the lateral semicircular canal to predict difficult cases with narrow facial recess.

NCT ID: NCT02925169 Completed - Child Clinical Trials

Shape and Dimensions of the Upper Airway in Infants Using Computed Tomography Imaging

Start date: April 2016
Phase: N/A
Study type: Observational

Cricoid is considered the narrowest part with the shape of airway defined as elliptical with the subglottis as the narrowest region. This study using imaging modality (2D CT images) is done to determine any differences in airway shape between infants and children, and to evaluate the dimensional transition between the subglottic area and the cricoid ring.

NCT ID: NCT02921035 Completed - Clinical trials for Relapsing Multiple Sclerosis (RMS)

Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Start date: June 30, 2016
Phase:
Study type: Observational

This is an open label, non randomized, uncontrolled, multicenter, single arm observational study. In this study, the enrolled subjects will be treated with Rebif human serum albumin (HSA)-free formulation (with or without RebiSmart) 44 microgram (mcg), subcutaneous (sc), thrice in a week (tiw) for 24 months.

NCT ID: NCT02919878 Recruiting - Clinical trials for Rectal Adenocarcinoma

Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer

Start date: December 2014
Phase: Phase 2
Study type: Interventional

Phase II Study of Neo-adjuvant Chemoradiotherapy using infusional Gemcitabine followed by Surgery for Locally Advanced (T3 and T4 or Node positive) Rectal Adenocarcinoma.

NCT ID: NCT02919371 Recruiting - Clinical trials for Renal Cell Carcinoma

Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)

Start date: December 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Combined sunitinib and bevacizumab in advanced renal cell carcinoma.

NCT ID: NCT02913482 Completed - Clinical trials for Muscular Atrophy, Spinal

Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

FIREFISH
Start date: December 23, 2016
Phase: Phase 2
Study type: Interventional

Open-label, multi-center clinical study is to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamics (PD), and efficacy of Risdiplam (RO7034067) in infants with Type 1 spinal muscular atrophy (SMA). The study consists of two parts, an exploratory dose finding part (Part 1) and a confirmatory part (Part 2) which will investigate Risdiplam (RO7034067) for 24-months at the dose selected in Part 1.